ENTITY

Biokin Pharmaceutical (2615 HK)

1
Analysis
Health Care • China
Biokin Pharmaceutical is a biopharmaceutical company engaged in the research, development, production, and supply of biomedicine. It specializes in large-molecule oncology therapeutics, including antibody drug conjugates (ADCs), multi-specific antibodies, and antibody radionuclide conjugates (ARCs), alongside offerings in anesthesia, parenteral nutrition, anti-infectives, pediatrics, and traditional Chinese medicines. The company was founded in 1996 and is headquartered in Chengdu, China.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x